BioClinica®, Inc., a specialty clinical trials services and technology provider, has partnered with advisory and outsourcing services company Kinapse on BioClinica’s Compass Intelligent Monitoring solution.
BioClinica®, Inc., a specialty clinical trials services and technology provider, has partnered with advisory and outsourcing services company Kinapse on BioClinica’s Compass Intelligent Monitoring solution. Kinapse chose the solution for clients that engage the company's change management process as they transition to RBM. Kinapse employs 450 professionals globally and has more than ten years of experience providing strategy and operations consultancy and capability-building programs, including RBM, to life sciences companies.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.